Diazepine-containing pharmaceutical compositions having a platelet-activating factor (PAF)-antagonist action

摘要

Platelet activating factor (Acetylglyceryl ester-phosphorylcholine, PAF) is known as a potent lipid mediator released by animal and human proinflammatory cells.; The invention relates to PAF-antagonistic pharmaceutical compositions containing as active ingredient one or more diazepines of the general formula I according to Claim. 1; These pharmaceutical compositions are used for treating pathological conditions and diseases, and which PAF is involved.